Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation Sarah A. MorrowPaola KrugerNektaria Alexandri SUMMARY OF RESEARCH Open access 20 February 2024 Pages: 497 - 499
Publisher Correction: Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation Sarah A. MorrowPaola KrugerNektaria Alexandri Publisher Correction Open access 19 March 2024 Pages: 501 - 501
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France Jonathan CironBertrand BourrePatrick Vermersch REVIEW Open access 15 March 2024 Pages: 503 - 518
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis Jerome de SezeDominique DiveChiara Zecca REVIEW Open access 08 April 2024 Pages: 519 - 533
Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder Stacey L. ClardySean J. PittockIna Zhang REVIEW Open access 09 May 2024 Pages: 535 - 549
Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG Feng LiangZhaoxu YinWei Zhang ORIGINAL RESEARCH Open access 01 March 2024 Pages: 551 - 562
The Association Between National Institutes of Health Stroke Scale Score and Clinical Outcome in Patients with Large Core Infarctions Undergoing Endovascular Treatment Lingyu Zhang**fu MaPengfei Wang ORIGINAL RESEARCH Open access 01 March 2024 Pages: 563 - 581
Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey Mary A. CurryRosángel E. CruzJill Jarecki ORIGINAL RESEARCH Open access 02 March 2024 Pages: 583 - 598
Impact of Immune Cells on Stroke Limited to Specific Subtypes: Evidence from Mendelian Randomization Study Chen ChenQi LiuLi Liu ORIGINAL RESEARCH Open access 06 March 2024 Pages: 599 - 609
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study Piero BarbantiGabriella Egeofor the Italian Migraine Registry study group ORIGINAL RESEARCH Open access 07 March 2024 Pages: 611 - 624
Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study Marco LuigettiDianna QuanDavid Adams ORIGINAL RESEARCH Open access 21 March 2024 Pages: 625 - 639
REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program Matthias SchwabAndrew ChanChristoph Grothe ORIGINAL RESEARCH Open access 26 March 2024 Pages: 641 - 653
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease Samuel FrankKaren E. AndersonMaria Chen ORIGINAL RESEARCH Open access 01 April 2024 Pages: 655 - 675
Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial Shoichiro SatoNaohisa HatakeyamaJohn R. Sims ORIGINAL RESEARCH Open access 06 April 2024 Pages: 677 - 695
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study Takao TakeshimaHikaru DoiMika Komori ORIGINAL RESEARCH Open access 06 April 2024 Pages: 697 - 714
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study **ao-Na MaWei FengQiang Xu ORIGINAL RESEARCH Open access 09 April 2024 Pages: 715 - 725
Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study **ao Zhang**nzhi HuTao Wang ORIGINAL RESEARCH Open access 15 April 2024 Pages: 727 - 737
Chinese Translation and Validation of the Center for Neurologic Study Lability Scale Lu ChenShan YeDongsheng Fan ORIGINAL RESEARCH Open access 16 April 2024 Pages: 739 - 747
Group-Based Trajectory Modeling of Fluid Balance in Elderly Patients with Acute Ischemic Stroke: Analysis from Multicenter ICUs Jia TangChangdong WuZhenguang Zhong ORIGINAL RESEARCH Open access 18 April 2024 Pages: 749 - 761
A Retrospective Analysis of Central and Peripheral Metabolic Characteristics in Patients with Cryptococcal Meningitis Jianglong QinLanwei NongSijun Li ORIGINAL RESEARCH Open access 20 April 2024 Pages: 763 - 784
Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations Anne Marie MorseRichard K. BoganMichael J. Thorpy ORIGINAL RESEARCH Open access 25 April 2024 Pages: 785 - 807
Epidemiology, Patient Characteristics, and Treatment Patterns of Myasthenia Gravis in Taiwan: A Population-Based Study Nai-Wen TsaiLi-Nien ChienJiann-Horng Yeh ORIGINAL RESEARCH Open access 27 April 2024 Pages: 809 - 824
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study Adam StrzelczykMarta MaschioVicente Villanueva ORIGINAL RESEARCH Open access 28 April 2024 Pages: 825 - 855
Unsupervised Machine Learning Revealed that Repeat Transcranial Magnetic Stimulation is More Suitable for Stroke Patients with Statin Chaohua CuiChanghong LiTianyu **a ORIGINAL RESEARCH Open access 30 April 2024 Pages: 857 - 868
Additional Results from Two Randomized, Placebo-Controlled Trials of Stiripentol in Dravet Syndrome Highlight a Rapid Antiseizure Efficacy with Longer Seizure-Free Periods Renzo GuerriniLaurent ChancharmeCatherine Chiron ORIGINAL RESEARCH Open access 09 May 2024 Pages: 869 - 884
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians Kathryn A. Wyman-ChickParichita ChaudhuryJoseph P. M. Kane PRACTICAL APPROACH Open access 08 May 2024 Pages: 885 - 906
Anti-N-methyl-d-aspartate Receptor Encephalitis in People Living with HIV: Case Report and Literature Review Jiang** Hui**hua WangBiao Zhu CASE SERIES Open access 26 March 2024 Pages: 907 - 916
Dental Adverse Effects of Anti-CD20 Therapies Hélène BartakTasnim FarehChristine Lebrun-Frenay CASE SERIES Open access 26 April 2024 Pages: 917 - 930
Correction: Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment Angelo GhezziR. F. Neuteboom Correction Open access 18 March 2024 Pages: 931 - 931
